Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 99

1.

Alum adjuvant: some of the tricks of the oldest adjuvant.

Kool M, Fierens K, Lambrecht BN.

J Med Microbiol. 2012 Jul;61(Pt 7):927-34. doi: 10.1099/jmm.0.038943-0. Epub 2011 Dec 15. Review.

PMID:
22174375
2.

Aluminum compounds as vaccine adjuvants.

Gupta RK.

Adv Drug Deliv Rev. 1998 Jul 6;32(3):155-172.

PMID:
10837642
3.

Adjuvant properties of aluminum and calcium compounds.

Gupta RK, Rost BE, Relyveld E, Siber GR.

Pharm Biotechnol. 1995;6:229-48. Review.

PMID:
7551219
4.

A comparative study of stress-mediated immunological functions with the adjuvanticity of alum.

Wang Y, Rahman D, Lehner T.

J Biol Chem. 2012 May 18;287(21):17152-60. doi: 10.1074/jbc.M112.347179. Epub 2012 Apr 3.

5.

Alum's adjuvant action: grease is the word.

Mbow ML, De Gregorio E, Ulmer JB.

Nat Med. 2011 Apr;17(4):415-6. doi: 10.1038/nm0411-415. No abstract available.

PMID:
21475229
6.

A CpG-containing oligodeoxynucleotide as an efficient adjuvant counterbalancing the Th1/Th2 immune response in diphtheria-tetanus-pertussis vaccine.

Sugai T, Mori M, Nakazawa M, Ichino M, Naruto T, Kobayashi N, Kobayashi Y, Minami M, Yokota S.

Vaccine. 2005 Nov 16;23(46-47):5450-6. Epub 2005 Jun 21.

PMID:
16006019
7.

Alum adjuvant boosts adaptive immunity by inducing uric acid and activating inflammatory dendritic cells.

Kool M, Soullié T, van Nimwegen M, Willart MA, Muskens F, Jung S, Hoogsteden HC, Hammad H, Lambrecht BN.

J Exp Med. 2008 Apr 14;205(4):869-82. doi: 10.1084/jem.20071087. Epub 2008 Mar 24.

8.

Contamination of DNase Preparations Confounds Analysis of the Role of DNA in Alum-Adjuvanted Vaccines.

Noges LE, White J, Cambier JC, Kappler JW, Marrack P.

J Immunol. 2016 Aug 15;197(4):1221-30. doi: 10.4049/jimmunol.1501565. Epub 2016 Jun 29.

9.

Host DNA released in response to aluminum adjuvant enhances MHC class II-mediated antigen presentation and prolongs CD4 T-cell interactions with dendritic cells.

McKee AS, Burchill MA, Munks MW, Jin L, Kappler JW, Friedman RS, Jacobelli J, Marrack P.

Proc Natl Acad Sci U S A. 2013 Mar 19;110(12):E1122-31. doi: 10.1073/pnas.1300392110. Epub 2013 Feb 27.

10.

Immunomodulatory properties of the vaccine adjuvant alum.

Oleszycka E, Lavelle EC.

Curr Opin Immunol. 2014 Jun;28:1-5. doi: 10.1016/j.coi.2013.12.007. Epub 2014 Jan 23. Review.

PMID:
24463269
11.

Carbohydrate-based immune adjuvants.

Petrovsky N, Cooper PD.

Expert Rev Vaccines. 2011 Apr;10(4):523-37. doi: 10.1586/erv.11.30. Review.

12.

Alum induces innate immune responses through macrophage and mast cell sensors, but these sensors are not required for alum to act as an adjuvant for specific immunity.

McKee AS, Munks MW, MacLeod MK, Fleenor CJ, Van Rooijen N, Kappler JW, Marrack P.

J Immunol. 2009 Oct 1;183(7):4403-14. doi: 10.4049/jimmunol.0900164. Epub 2009 Sep 4.

13.

The vaccine adjuvant alum inhibits IL-12 by promoting PI3 kinase signaling while chitosan does not inhibit IL-12 and enhances Th1 and Th17 responses.

Mori A, Oleszycka E, Sharp FA, Coleman M, Ozasa Y, Singh M, O'Hagan DT, Tajber L, Corrigan OI, McNeela EA, Lavelle EC.

Eur J Immunol. 2012 Oct;42(10):2709-19. doi: 10.1002/eji.201242372. Epub 2012 Aug 6.

14.

Comparing the effect of IL-12 genetic adjuvant and alum non-genetic adjuvant on the efficiency of the cocktail DNA vaccine containing plasmids encoding SAG-1 and ROP-2 of Toxoplasma gondii.

Khosroshahi KH, Ghaffarifar F, Sharifi Z, D'Souza S, Dalimi A, Hassan ZM, Khoshzaban F.

Parasitol Res. 2012 Jul;111(1):403-11. doi: 10.1007/s00436-012-2852-7. Epub 2012 Feb 21.

PMID:
22350714
15.

The cationic lipid, diC14 amidine, extends the adjuvant properties of aluminum salts through a TLR-4- and caspase-1-independent mechanism.

Wilmar A, Lonez C, Vermeersch M, Andrianne M, Pérez-Morga D, Ruysschaert JM, Vandenbranden M, Leo O, Temmerman ST.

Vaccine. 2012 Jan 5;30(2):414-24. doi: 10.1016/j.vaccine.2011.10.071. Epub 2011 Nov 7.

PMID:
22075093
16.

CpG-containing oligodeoxynucleotides augment and switch the immune responses of cattle to bovine herpesvirus-1 glycoprotein D.

Rankin R, Pontarollo R, Gomis S, Karvonen B, Willson P, Loehr BI, Godson DL, Babiuk LA, Hecker R, van Drunen Littel-van den Hurk S.

Vaccine. 2002 Jul 26;20(23-24):3014-22.

PMID:
12126915
17.

CpG DNA induces stronger immune responses with less toxicity than other adjuvants.

Weeratna RD, McCluskie MJ, Xu Y, Davis HL.

Vaccine. 2000 Mar 6;18(17):1755-62.

PMID:
10699323
18.

Disparate adjuvant properties among three formulations of "alum".

Cain DW, Sanders SE, Cunningham MM, Kelsoe G.

Vaccine. 2013 Jan 11;31(4):653-60. doi: 10.1016/j.vaccine.2012.11.044. Epub 2012 Nov 29.

19.

Illuminating alum.

Schubert C.

Nat Med. 2009 Sep;15(9):985. doi: 10.1038/nm0909-985. No abstract available.

PMID:
19734863
20.

Alum increases antigen uptake, reduces antigen degradation and sustains antigen presentation by DCs in vitro.

Ghimire TR, Benson RA, Garside P, Brewer JM.

Immunol Lett. 2012 Sep;147(1-2):55-62. doi: 10.1016/j.imlet.2012.06.002. Epub 2012 Jun 23.

Supplemental Content

Support Center